Resources

Type of publications
Regions
Diseases
4760 results found
2025 ∙ SAGE
SAGE Evidence to Recommendation Framework: Reduced-dose (1p+1) schedules
Evidence to recommendation table Pneumococcal disease
Download:
2025 ∙ WHO
WHO position paper on Pneumococcal conjugate vaccines in infants and children aged <5 years – September 2025
Position paper Pneumococcal disease
Download:
2025 ∙ SAGE
SAGE Evidence to Recommendation Framework: Multi-age cohort PCV campaigns
Evidence to recommendation table Pneumococcal disease
Download:
2025 ∙ SAGE
SAGE Evidence to Recommendation Framework: Extended-valency PCVs
Evidence to recommendation table Pneumococcal disease
Download:
2025 ∙ Conseil Supérieur de la Santé (CSS)
Post-Exposure Prophylaxis (PEP) for Measles in Belgium
Recommendation Europe Belgium Measles
Download:
2025 ∙ ATAGI
ATAGI statement on RSV administration errors
Recommendation Western Pacific Australia RSV (Respiratory syncytial virus)
Download:
2025 ∙ Vittrup, D. M. Charabi, S. Jensen, A. Stensballe, L. G.
A systematic review and meta-analysis of adverse events following measles-containing vaccines in infants less than 12 months of age
Newborn Measles Safety Administration
Rating:
Critically low
2025 ∙ Gebreal, A. Ashmawy, R. Ahmed, M. J. Khattab, M. Shata, K. S. Elmansoury, A. Estifanos, H. Eissa, M. H. Ahmed, W. Hasan, H. M. Mahmutaj, A. Abourady, Y. El Arab, L. E. Abass, M. Adhyaru, R. Ghazy, R. M.
A systematic review and meta-analysis on parental uptake and willingness to vaccinate children against human papillomavirus in the Eastern Mediterranean Region
Eastern Mediterranean Parents/caregivers Human papillomavirus (HPV) Acceptance Coverage
Rating:
Not applicable
2025 ∙ Metelmann, S. Thompson, A. Donten, A. Oke, S. Sun, S. Borrow, R. Xu, F. Vivancos, R. Decraene, V. Pellis, L. Hall, I.
A systematic review to identify research gaps in studies modeling MenB vaccinations against Neisseria infections
All age groups Meningococcal disease Modeling
Rating:
Not applicable
2025 ∙ Mink, S. Wilhelm, F. Cadamuro, J. Reimann, P. Fraunberger, P.
Anti-SARS-CoV-2 Antibodies in Long-COVID-Markers of Protection or Elevated Risk? A Systematic Review
All age groups Healthcare workers COVID-19 Efficacy/effectiveness
Rating:
Critically low
Loading...